Education
About Us
Working with TipRanks
Follow Us
Stephane Bancel Insider Profile
88 Followers
Stephane Bancel, Director at BG Medicine, holds 1.18M shares in Generate Biomedicines, Inc. (Ticker: GENB), holds 21.96M shares in Moderna (Ticker: MRNA), holds 123.17K shares in BG Medicine (Ticker: BGMD).
Stephane Bancel has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Stephane Bancel holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Stephane Bancel
Stephane Bancel's Trading History
BG Medicine
Nov 19, 2012
Director
Informative Buy
126.00K
―
Moderna
Feb 13, 2026
CEO, Director
Uninformative Buy
―
$1.21B
Generate Biomedicines, Inc.
Mar 02, 2026
Director
Uninformative Buy
―
$14.47M
List of latest transactions for each holding click on a transaction to see Stephane Bancel's performance on stock
You May Also Like
Stephane Bancel insider profile FAQ
What is the percentage of profitable transactions made by Stephane Bancel?
The percentage of profitable transactions made by Stephane Bancel is ―.
What is the average return per transaction made by Stephane Bancel?
The average return per transaction made by Stephane Bancel is ―.
What stocks does Stephane Bancel hold?
Stephane Bancel holds: BGMD, MRNA, GENB stocks.
What was Stephane Bancel’s latest transaction?
Stephane Bancel latest transaction was an Uninformative Buy of ―.
What was Stephane Bancel's most profitable transaction?
Stephane Bancel’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Stephane Bancel's role in BG Medicine?
Stephane Bancel's role in BG Medicine is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.